Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
Tel: |
18818260767 |
Email: |
sales@chemegen.com |
Products Intro: |
Product Name:Axitinib-13C-d3 CAS:1261432-00-1 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
Company Name: |
Manhag Testing Technology Co., Ltd
|
Tel: |
020-020-3846236 17688849268 |
Email: |
2443244976@qq.com |
Products Intro: |
Product Name:Axitinib-[13C,d3] CAS:1261432-00-1 Purity:1mg Package:1mg
|
|
| Axitinib-13C-d3 Basic information |
Product Name: | Axitinib-13C-d3 | Synonyms: | Axitinib-13C-d3;[13C,2H3]-Axitinib;(E)-N-(methyl-13C-d3)-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide | CAS: | 1261432-00-1 | MF: | | MW: | 0 | EINECS: | | Product Categories: | | Mol File: | Mol File | ![Axitinib-13C-d3 Structure]() |
| Axitinib-13C-d3 Chemical Properties |
storage temp. | Store at -20°C | solubility | DMSO: soluble | form | A solid | color | White to off-white |
| Axitinib-13C-d3 Usage And Synthesis |
Description | Axitinib-13C-d3 is intended for use as an internal standard for the quantification of axitinib by GC- or LC-MS. Axitinib is a VEGFR inhibitor (IC50s = 1.2, 0.25, and 0.29 nM for VEGFR1, -2, and -3, respectively). It also inhibits c-Kit and PDGFRβ (IC50s = 1.7 and 1.6 nM, respectively). It inhibits VEGF-induced migration of and tube formation by human umbilical vein endothelial cells (HUVECs). Axitinib (1-100 mg/kg) reduces microvessel density, a marker of angiogenesis, and tumor growth in MV522 colon carcinoma, A375 melanoma, SN12C-GFP renal carcinoma, and U87 glioma mouse xenograft models in a dose-dependent manner. Formulations containing axitinib have been used in the treatment of renal cell carcinoma. |
| Axitinib-13C-d3 Preparation Products And Raw materials |
|